On May 11, shares in the Hillenbrand Inc. company were selling at $46.57.
Hillenbrand Inc. employs 11,000 people and has reported $153,400,000 in income as of May 11.
In the fluctuating stock market, healthcare and technology stocks are viewed as the safest bets for long-term gains.
Besty Kuekcer with Benzinga.com said healthcare-related stocks, such as hospital conglomerates and insurance companies, have weathered numerous economic crises and still make a profit, meaning they’re a stable investment.
While technology stocks can be more risky, given the boom-bust nature of new tech companies, Kuecker recommended a diverse portfolio of tech companies to strike it big when companies succeed or sell to other larger companies.
For short-term investments, Kuecker recommended “consumer discretionary” stocks, which are sensitive to economic changes but can rise greatly on the back of a strong economy.
Nothing in this article is to be assumed as financial advice.
Individual companies can have several different types of shares across many stock markets. It is possible for different types of shares to see different results on the market.
| Company Name | % of Change in Last Year | Selling Price |
|---|---|---|
| Bellerophon Therapeutics Inc. | 920.28% | $8.65 |
| Viking Therapeutics Inc. | 883.26% | $22.91 |
| Cabaletta Bio Inc. | 790.6% | $13.27 |
| Biomea Fusion Inc. | 748.7% | $32.76 |
| Terns Pharmaceuticals Inc. | 735.76% | $12.62 |
| Renewable Innovations Inc | 645.99% | $0.7449 |
| Sustainable Projects Group Inc | 612.59% | $0.3 |
| Freedom Holdings Inc. | 605% | $0.141 |
| Prometheus Biosciences Inc. | 604.22% | $193.8 |
| 89Bio Inc. | 566.29% | $17.59 |
| Ardelyx Inc. | 555.34% | $4.28 |
| Cymabay Therapeutics Inc. | 470.83% | $10.28 |
| Reviva Pharmaceuticals Holdings, Inc. | 429.77% | $7.92 |
| Arcellx Inc | 423.34% | $46.63 |
| TG Therapeutics Inc. | 418.62% | $33.71 |
| Rhythm Pharmaceuticals Inc. | 412.04% | $16.59 |
| Nuvalent Inc. | 401.13% | $40.09 |
| Akero Therapeutics Inc. | 400.21% | $46.97 |
| MineralRite Corp | 400% | $0.0005 |
| Groove Botanicals Inc | 384.85% | $0.16 |
| Pliant Therapeutics Inc. | 360.57% | $22.66 |
| Harrow Health Inc. | 358.04% | $27.07 |
| Tingo Group Inc | 355.9% | $2.9 |
| Immunovant Inc. | 352.48% | $18.28 |
| Pulse Biosciences Inc. | 347.65% | $7.61 |
| Digital Brand Media & Marketing Group Inc. | 346.15% | $0.0035 |
| Madrigal Pharmaceuticals Inc. | 338.34% | $288.12 |
| Ameritek Ventures Inc | 333.33% | $0.0065 |
| Atlas Lithium Corp | 331.61% | $20.07 |
| Voip-Pal.Com Inc. | 330.11% | $0.08 |
| Reviv3 Procare Co. | 323.65% | $0.498 |
| Aldeyra Therapeutics Inc. | 314.06% | $10.31 |
| Aldeyra Therapeutics Inc. | 314.06% | $10.31 |
| Enliven Therapeutics Inc | 308.12% | $19.1 |
| Greenlite Ventures Inc. | 307.08% | $0.69 |
| Reneo Pharmaceuticals Inc. | 295.33% | $8.46 |
| Elf Beauty Inc. | 277.61% | $89.57 |
| Cannabis Suisse Corp. | 271.14% | $0.0746 |
| Clearone Inc. | 267.71% | $2.1 |
| Rain Therapeutics Inc. | 263.92% | $9.28 |
| Blue Dolphin Energy Co. | 259.49% | $1.97 |
| Reata Pharmaceuticals Inc. | 258.64% | $88.01 |
| M&F Bancorp Inc. | 257.08% | $23.21 |
| ImmunoGen Inc. | 251.96% | $13.48 |
| Aehr Test Systems | 244.96% | $27.7 |
| Amylyx Pharmaceuticals Inc | 238.58% | $28.61 |
| VPR Brands LP | 236.68% | $0.1675 |
| Muscle Maker Inc. | 224.31% | $1.33 |
| Carrols Restaurant Group Inc. | 221.38% | $4.66 |
| Dinewise Inc. | 215% | $0.0504 |